Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinoma identifies potential novel therapeutic options


Ghassan K. Abou-Alfa1, John T. Miura, T. Clark Gamblin, Joanne Xiu, Sherri Z. Millis, Zoran Gatalica, Sandeep K. Reddy, Celina Ang, Nelson S. Yee


Effective treatment strategies for hepatocellular carcinoma (HCC) remain limited. Identification of additional therapies remains paramount as currently available agents have resulted in marginal improvements in overall survival.

Download Publication